46. Empiric Antibiotic Therapy and Readmission Rate in Patients with Urinary Tract Infection
Session: Posters in the Park: Posters in the Park
Wednesday, October 3, 2018: 5:30 PM
Room: N Hall D Opening Reception and Posters in the Park Area
Background: Implementing ASP can be challenging in the emergency department. However, based on the 30 day risk factors identified for UTI, such as empiric antibiotic therapy, ASP has shown to increase the rate of treatment success and decrease 30 day readmission in patients with UTI. This retrospective study aimed to examine if there is a difference in 30-day readmission rate between patients who were prescribed an antibacterial with high (≥90%) susceptibility and moderate to low (<90%) susceptibility.

Methods: Retrospective cohort study of adult patients from emergency department with positive urine cultures at a tertiary care medical center in Bangor, Maine. Study began by developing a community specific urine antibiogram from 2013 to 2016. Then, patients were divided into two groups depending on empiric antibiotic given at discharged according to the susceptibility of antibiotic defined from the community specific urine antibiogram: high susceptibility defined as greater than or equal to 90% or moderate to low defined as less than 90%. Primary outcome was to evaluate 30-day readmission between the susceptibility groups.

Results: A total of 594 patients were included for analysis. E. coli, Klebsiella spp. and Proteus spp. were the most common urine pathogens (75.5%, 9.1% and 3.2%). A total of 55.1% patients were given a high susceptibility antibiotic (n=327) and the remaining patients (n=267) were in the moderate to low susceptibility group. Readmission to the ED or hospital within 30 days with signs and symptoms of UTI was higher in moderate to low susceptibility (14.2%) compared to that of high susceptibility (7.95%); p=0.0140. After adjusting for confounders, moderate to low susceptibility adjusted odds ratio was 1.74; 95% CI (1.01, 2.99); p=0.047.

Conclusion: A patient empirically treated with a moderate to low susceptibility antibiotic such as trimethoprim/sulfamethoxazole, the odds of being readmitted within 30 days are 1.74 times greater than the odds of empiric treatment with a high susceptibility antibiotic (e.g. cephalexin). Creating a community source specific urinary pathogen antibiogram to base the empiric antibacterial therapy for ED patients with urinary tract infection may be a useful tool in reduction of 30 day readmission rates.

Soojin Lee, PharmD, Eastern Maine Medical Center, Bangor, ME, Sara Jones, PharmD, BCPS, Pharmacy, Eastern Maine Medical Center, Bangor, ME and Anthony M. Casapao, PharmD, University of Florida College of Pharmacy, Jacksonville, FL


S. Lee, None

S. Jones, None

A. M. Casapao, None

See more of: Posters in the Park
See more of: Posters in the Park

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.